"R" for "Renal" and for "Risk" Refining Risk Stratification for Stroke in Atrial Fibrillation

被引:22
作者
Camm, A. John [1 ]
Savelieva, Irene [1 ]
机构
[1] St Georges Univ London, Div Clin Sci, London SW17 0RE, England
关键词
Editorials; atrial fibrillation; prevention and control; risk; PREDICTING STROKE; THROMBOEMBOLISM; METAANALYSIS; PREVENTION; GUIDELINES; MANAGEMENT; WARFARIN; SCHEMES; THERAPY; DISEASE;
D O I
10.1161/CIRCULATIONAHA.112.147512
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:169 / 171
页数:3
相关论文
共 14 条
[1]
Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]
[2]
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study [J].
Friberg, Leif ;
Rosenqvist, Marten ;
Lip, Gregory Y. H. .
EUROPEAN HEART JOURNAL, 2012, 33 (12) :1500-+
[3]
2011 ACCF/AHA/HRS Focused Updates Incorporated into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, Davis S. ;
Crijns, Harry J. ;
Curtis, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Kay, G. Neal ;
Le Huezey, Jean-Yves ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, L. Samuel .
CIRCULATION, 2011, 123 (10) :E269-E367
[4]
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870
[5]
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study [J].
Go, Alan S. ;
Fang, Margaret C. ;
Udaltsova, Natalia ;
Chang, Yuchiao ;
Pomernacki, Niela K. ;
Borowsky, Leila ;
Singer, Daniel E. .
CIRCULATION, 2009, 119 (10) :1363-1369
[6]
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].
Hart, Robert G. ;
Pearce, Lesly A. ;
Aguilar, Maria I. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867
[7]
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial [J].
Holmes, David R. ;
Reddy, Vivek Y. ;
Turi, Zoltan G. ;
Doshi, Shephal K. ;
Sievert, Horst ;
Buchbinder, Maurice ;
Mullin, Christopher M. ;
Sick, Peter .
LANCET, 2009, 374 (9689) :534-542
[8]
Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk [J].
Lip, Gregory Y. H. .
EUROPACE, 2011, 13 (02) :145-148
[9]
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation [J].
Lip, Gregory Y. H. ;
Nieuwlaat, Robby ;
Pisters, Ron ;
Lane, Deirdre A. ;
Crijns, Harry J. G. M. .
CHEST, 2010, 137 (02) :263-272
[10]
Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation [J].
Miller, Corey S. ;
Grandi, Sonia M. ;
Shimony, Avi ;
Filion, Kristian B. ;
Eisenberg, Mark J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (03) :453-460